Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

CDC Science Clips

Healthcare Economics

  1. Blue Cross partners with state to provide childhood vaccines
    Idaho Department of Health and Welfare. 2009 June 15.

  2. Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get with the Guidelines-Coronary Artery Disease program)
    Ambardekar AV, Fonarow GC, Dai D, Peterson ED, Hernandez AF, Cannon CP, Krantz MJ.
    Am J Cardiol. 2010 ;105(2):139-43.

  3. The impact of self-insuring for workers' compensation on the incidence rates of worker injury and illness
    Asfaw A, Pana-Cryan R.
    J Occup Environ Med. 2009 Nov 25.

  4. Trends in medical care expenditures of US adults with arthritis and other rheumatic conditions 1997 to 2005
    Cisternas MG, Murphy LB, Yelin EH, Foreman AJ, Pasta DJ, Helmick CG.
    J Rheumatol. 2009 Oct 1.

  5. Net financial gain or loss from vaccination in pediatric medical practices
    Coleman MS, Lindley MC, Ekong J, Rodewald L.
    Pediatrics. 2009 ;124(SUPPL. 5):S472-S491.

  6. Trends in healthcare utilization for diarrhea and rotavirus disease in privately insured US children <5 years of age, 2001-2006
    Cortes JE, Curns AT, Tate JE, Parashar UD.
    Pediatr Infect Dis J. 2009 Jul 9.

  7. Changes in Medicaid physician fees and patterns of ambulatory care
    Decker SL.
    Inquiry. 2009 Fall;46(3):291-304.

  8. The personal financial burden of cancer for the working-aged population
    Finkelstein EA, Tangka FK, Trogdon JG, Sabatino SA, Richardson LC.
    Am J Manag Care. 2009 Nov;15(11):801-6.

  9. Annual medical spending attributable to obesity: payer-and service-specific estimates
    Finkelstein EA, Trogdon JG, Cohen JW, Dietz W.
    Health Aff (Millwood). 2009 Sep-Oct;28(5):w822-31.

  10. Assessing cost effectiveness of empirical and prophylactic therapy for managing leptospirosis outbreaks
    Galloway RL, Levett PN, Tumeh JW, Flowers CR.
    Epidemiol Infect. 2009 Sep;137(9):1323-32.

  11. Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study
    Gregg EW, Karter AJ, Gerzoff RB, Safford M, Brown AF, Tseng CW, Waitzfielder B, Herman WH, Mangione CM, Selby JV, Thompson TJ, Dudley RA.
    Med Care. 2009 Dec 8.

  12. Cost-effectiveness of a behavioral weight loss intervention for low-income women: the Weight-Wise Program
    Gustafson A, Khavjou O, Stearns SC, Keyserling TC, Gizlice Z, Lindsley S, Bramble K, Garcia B, Johnston L, Will J, Poindexter P, Ammerman AS, Samuel-Hodge CD.
    Prev Med. 2009 Nov;49(5):390-5.

  13. Financing vaccination of children and adolescents: National Vaccine Advisory Committee recommendations
    Lindley MC, Birkhead GS, Almquist JR, Clover RD, Dekker C, Feinberg M, Fergie J, Gordon LK, Humiston SG, Jackson LA, Lovell Jr C, Mason JO, McCormick M, Nevin-Woods C, Parnell T, Pavia A, Riley LE, Abramson JS, Coleman MS, Edwards B, Freed GL, Gellin B, Greenbaum E, Haddix AC, Hinman AR, Johnson CB, Kelman J, Klein JO, Orenstein WA, Pauly M, Pisani AA, Rodewald LE, Rosenberg A, Salesa J, Shen AK, Wallace G, Wilson JJ, Wisniewski AC.
    Pediatrics. 2009 ;124(SUPPL. 5):S558-S562.

  14. Financing the delivery of vaccines to children and adolescents: challenges to the current system
    Lindley MC, Shen AK, Orenstein WA, Rodewald LE, Birkhead GS.
    Pediatrics. 2009 ;124(SUPPL. 5):S548-S557.

  15. Advancing the science of health care costing
    Lipscomb J, Barnett PG, Brown ML, Lawrence W, Yabroff KR.
    Med Care. 2009 Jul;47(7 Suppl 1):S120-6.[Request a copy via DocExpress]

  16. The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda
    Marseille E, Kahn JG, Pitter C, Bunnell R, Epalatai W, Jawe E, Were W, Mermin J.
    Appl Health Econ Health Policy. 2009 ;7(4):229-43.

  17. The societal cost of tuberculosis: Tarrant County, Texas, 2002
    Miller TL, McNabb SJ, Hilsenrath P, Pasipanodya J, Drewyer G, Weis SE.
    Ann Epidemiol. 2010 Jan;20(1):1-7.

  18. From the American Academy of Pediatrics: Policy statements--Supplemental Security Income (SSI) for children and youth with disabilities
    Murphy NA, Burke R, Desch LW, Duby JC, Elias ER, Levy SE, Liptak GS, McNeal D, Myers SM, Norwood Jr KW, Sagerman PJ, Peacock G, Council on Children With Disabilities.
    Pediatrics. 2009 Dec;124(6):1702-8.

  19. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States
    Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD.
    Pediatr Blood Cancer. 2009 Oct;53(4):642-6.

  20. Healthcare expenditures for privately insured people with cystic fibrosis
    Ouyang L, Grosse SD, Amendah DD, Schechter MS.
    Pediatr Pulmonol. 2009 Sep 18;44(10):989-96.

  21. Billing third party payers for vaccines: state and local health department perspectives
    Quintanilla C, Duncan L, Luther L.
    J Public Health Manag Pract. 2009 Sep-Oct;15(5):E1-5.

  22. Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States
    Ray GT, Pelton SI, Klugman KP, Strutton DR, Moore MR.
    Vaccine. 2009 Nov 5;27(47):6483-94.

  23. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship
    Roberts RR, Hota B, Ahmad I, Scott II RD, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA.
    Clin Infect Dis. 2009 Sep 9;49(8):1175-84.

  24. Role of health insurance in financing vaccinations for children and adolescents in the United States
    Shen AK, Hunsaker J, Gazmararian JA, Lindley MC, Birkhead GS.
    Pediatrics. 2009 ;124(SUPPL. 5):S522-S531.

  25. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States
    Shen AK, Rodewald LE, Birkhead GS.
    Pediatrics. 2009 ;124(SUPPL. 5):S540-S547.

  26. Costs and effectiveness of partner counseling and referral services with rapid testing for HIV in Colorado and Louisiana, United States
    Shrestha RK, Begley EB, Hutchinson AB, Sansom SL, Song B, Voorhees K, Busby A, Carrel J, Burgess S.
    Sex Transm Dis. 2009 ;36(10):637-641.

  27. Underinsurance and adolescent immunization delivery in the United States
    Smith PJ, Lindley MC, Shefer A, Rodewald LE.
    Pediatrics. 2009 ;124(SUPPL. 5):S515-S521.

  28. Underinsurance and pediatric immunization delivery in the United States
    Smith PJ, Molinari NA, Rodewald LE.
    Pediatrics. 2009 ;124(SUPPL. 5):S507-S514.

  29. Developing and testing a cost-assessment tool for cancer screening programs
    Subramanian S, Ekwueme DU, Gardner JG, Trogdon J.
    Am J Prev Med. 2009 Sep;37(3):242-7.

  30. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in Kenya
    Tate JE, Rheingans RD, O'Reilly CE, Obonyo B, Burton DC, Tornheim JA, Adazu K, Jaron P, Ochieng B, Kerin T, Calhoun L, Hamel M, Laserson K, Breiman RF, Feikin DR, Mintz ED, Widdowson MA.
    J Infect Dis. 2009 Nov 1;200 Suppl 1:S76-84.

  31. Health insurance and mortality in US adults
    Wilper A, Woolhandler S, Lasser K, McCormick D, Bor D, Himmelstein D.
    Am J Public Health. 2009 ;99(12):2289-95.

  32. Cost of universal influenza vaccination of children in pediatric practices
    Yoo BK, Szilagyi PG, Schaffer SJ, Humiston SG, Rand CM, Albertin CS, Vincelli P, Blumkin AK, Shone LP, Coleman MS.
    Pediatrics. 2009 ;124(SUPPL. 5):S499-S506.

  33. Impact of type of insurance plan on access and utilization of health care services for adults aged 18-64 years with private health insurance: United States, 2007-2008
    Cohen RA.
    NCHS Data Brief. 2010 Feb(28):1-8.

  34. Do reduced inpatient costs associated with highly active antiretroviral therapy (HAART) balance the overall cost for HIV treatment?
    Farnham PG.
    Appl Health Econ Health Policy. 2010 ;8(2):75-88.

  35. Global healthcare expenditure on diabetes for 2010 and 2030
    Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G.
    Diabetes Res Clin Pract. 2010 Feb 18.

  36. Estimates of state-level health-care expenditures associated with disability
    Anderson WL, Armour BS, Finkelstein EA, Wiener JM.
    Public Health Rep. 2010 January-February;125(1):44-51.

  37. What is the value for money of prenatal carrier screening for spina muscular atrophy? Too soon to say
    Grosse SD.
    Am J Obstet Gynecol. 2010 Mar;202(3):209-11.

  38. Treatment cost of acute gonococcal infections: estimates from employer-sponsored private insurance claims data in the United States, 2003-2007
    Owusu-Edusei K, Gift TL, Chesson HW.
    Sex Transm Dis. 2010 Mar 8.

  39. The direct cost of chlamydial infections: estimates for the employer-sponsored privately insured population in the United States, 2003-2007
    Owusu-Edusei K, Doshi SR, Apt BS, Gift TL.
    Sex Transm Dis. 2010 Apr 21.

  40. Long-term trends in Medicare payments in the last year of life
    Riley GF, Lubitz JD.
    Health Serv Res. 2010 Feb 9.

  41. State variation in underinsurance among children with special health care needs in the United States
    Kogan MD, Newacheck PW, Blumberg SJ, Heyman KM, Strickland BB, Singh GK, Zeni MB.
    Pediatrics. 2010 Apr;125(4):673-80.

  42. Cancer treatment cost in the United States
    Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA.
    Cancer. 2010 .

  43. Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States
    Saraiya M, McCaig LF, Ekwueme DU.
    Am J Manag Care. 2010 ;16(6):e137-44.

  44. Dental insurance for persons under age 65 years with private health insurance: United States, 2008
    Bloom B, Cohen RA.
    NCHS Data Brief. 2010 Jun(40):1-8.

  45. Cancer treatment cost in the United States: has the burden shifted over time?
    Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA.
    Cancer. 2010 May 10.

  46. External costs of risky health behaviors associated with leading actual causes of death in the US: a review of the evidence and implications for future research
    Zohrabian A, Philipson TJ.
    Int J Environ Res Public Health. 2010 Jun;7(6):2460-2472.

  47. Medical costs averted by HIV prevention efforts in the United States, 1991-2006
    Farnham PG, Holtgrave DR, Sansom SL, Hall HI.
    J Acquir Immune Defic Syndr. 2010 Aug 15;54(5):565-7.

  48. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review
    Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X.
    Diabetes Care. 2010 Aug;33(8):1872-94.

  49. Trends and characteristics of US emergency department visits, 1997-2007
    Tang N, Stein J, Hsia RY, Maselli JH, Gonzales R.
    JAMA. 2010 Aug 11;304(6):664-70.

  50. High costs of influenza: direct medical costs of influenza disease in young children
    Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, Edwards KM, Molinari NA, Donauer S, Henderson D, Ambrose S, Kent D, Poehling K, Weinberg GA, Griffin MR, Hall CB, Finelli L, Bridges C, Staat MA.
    Vaccine. 2010 Jul 12;28(31):4913-9.

  51. Cost of rapid HIV testing at 45 U.S. hospitals
    Pinkerton SD, Bogart LM, Howerton D, Snyder S, Becker K, Asch SM.
    AIDS Patient Care STDS. 2010 Jul;24(7):409-13.

  52. Employment impact and financial burden for families of children with fragile X syndrome: findings from the National Fragile X Survey
    Ouyang L, Grosse S, Raspa M, Bailey D.
    J Intellect Disabil Res. 2010 Aug 26.

  53. Medical expenditures associated with diabetes acute complications in privately-insured U.S. youth
    Shrestha SS, Zhang P, Barker L, Imperatore G.
    Diabetes care. 2010 Sep 15.

  54. Underinsurance among children in the United States
    Kogan MD, Newacheck PW, Blumberg SJ, Ghandour RM, Singh GK, Strickland BB, van Dyck PC.
    N Engl J Med. 2010 Aug 26;363(9):841-51.

  55. Federal funding for reporting cases of HIV infection in the United States, 2006
    Page MJ, Harrison KM, Wei X, Hall HI.
    Public Health Rep. 2010 Sep-Oct;125(5):718-27.

  56. Estimating the direct outpatient medical cost per episode of primary and secondary syphilis in the United States: insured population perspective, 2003-2007
    Owusu-Edusei Jr K, Hoover KW, Tao G.
    Sex Transm Dis. 2010 Sep 24.

  57. Patients' willingness to discuss trade-offs to lower their out-of-pocket drug costs
    Tseng CW, Waitzfelder BE, Tierney EF, Gerzoff RB, Marrero DG, Piette JD, Karter AJ, Curb JD, Chung R, Mangione CM, Crosson JC, Dudley RA.
    Arch Intern Med. 2010 Sep 13;170(16):1502-4.

  58. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods
    Roberts RR, Scott 2nd RD, Hota B, Kampe LM, Abbasi F, Schabowski S, Ahmad I, Ciavarella GG, Cordell R, Solomon SL, Hagtvedt R, Weinstein RA.
    Med Care. 2010 Oct 11.

  59. Costs of heart failure-related hospitalizations in patients aged 18 to 64 years
    Wang G, Zhang Z, Ayala C, Wall HK, Fang J.
    Am J Manag Care. 2010 Oct;16(10):769-76.

  60. Coverage and preventive screening
    Meeker D, Joyce GF, Malkin J, Teutsch SM, Haddix AC, Goldman DP.
    Health Serv Res. 2010 Oct 28.

  61. The economic implications of influenza vaccination for adults with asthma
    Trogdon JG, Nurmagambetov TA, Thompson HF.
    Am J Prev Med. 2010 Nov;39(5):403-10.

  62. How health insurance design affects access to care and costs, by income, in eleven countries
    Schoen C, Osborn R, Squires D., Doty MM, Pierson R, Applebaum S.
    Health Affairs. 2010 Nov 2010;29(12).

  63. Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women
    Subramanian S, Trogdon J, Ekwueme DU, Gardner JG, Whitmire JT, Rao C.
    Med Care. 2010 Nov 12.

  64. A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics
    Cho BH, Hicks KA, Honeycutt AA, Hupert N, Khavjou O, Messonnier M, Washington ML.
    J Public Health Manag Pract. 2011 January/February;17(1):E22-E28.

  65. Economic analysis of the global polio eradication initiative
    Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SG, Linkins J, Sutter RW, Aylward RB, Thompson KM.
    Vaccine. 2010 Dec 16;29(2):334-43.

  66. Financial barriers to the adoption of combination vaccines by pediatricians
    Gidengil CA, Dutta-Linn MM, Messonnier ML, Rusinak D, Lieu TA.
    Arch Pediatr Adolesc Med. 2010 Dec;164(12):1138-44.

  67. The tale of two serologic tests to screen for syphilis-treponemal and nontreponemal: does the order matter?
    Owusu-Edusei K, Koski KA, Ballard RC.
    Sex Transm Dis. 2010 Dec 22.

  68. Costs of asthma in the United States: 2002-2007
    Barnett SB, Nurmagambetov TA.
    J Allergy Clin Immunol. 2011 Jan;127(1):145-52.

  69. The economic value of improving the health of disadvantaged Americans
    Schoeni RF, Dow WH, Miller WD, Pamuk ER.
    Am J Prev Med. 2011 Jan;40(1 Suppl 1):S67-72.

  70. The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs
    Lin JM, Resch SC, Brimmer DJ, Johnson A, Kennedy S, Burstein N, Simon CJ.
    Cost Eff Resour Alloc. 2011 ;9(1):1.

  71. Costs of asthma in the United States: 2002-2007
    Barnett SB, Nurmagambetov TA.
    J Allergy Clin Immunol. 2011 Jan;127(1):145-52.

  72. Health economics of dengue: a systematic literature review and expert panel's assessment
    Beatty ME, Beutels P, Meltzer MI, Shepard DS, Hombach J, Hutubessy R, Dessis D, Coudeville L, Dervaux B, Wichmann O, Margolis HS, Kuritsky JN.
    Am J Trop Med Hyg. 2011 Mar;84(3):473-488.

  73. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs
    Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, Blandford JM.
    AIDS. 2011 Mar 15.

  74. The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy
    Rein DB, Wittenborn JS, Zhang X, Allaire BA, Song MS, Klein R, Saaddine JB.
    Health Serv Res. 2011 Apr 14.

  75. Medical expenditures of children in the United States with fetal alcohol syndrome
    Amendah DD, Grosse SD, Bertrand J.
    Neurotoxicol Teratol. 2011 Mar-Apr;33(2):322-4.

  76. Medical expenditures associated with diabetes among privately insured U.S. youth in 2007
    Shrestha SS, Zhang P, Albright A, Imperatore G.
    Diabetes Care. 2011 May;34(5):1097-101.

  77. Healthcare utilization and cost of pneumococcal disease in the United States
    Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA.
    Vaccine. 2011 Apr 18;29(18):3398-412.

  78. Why behavioral and environmental interventions are needed to improve health at lower cost
    Milstein B, Homer J, Briss P, Burton D, Pechacek T.
    Health Aff (Millwood). 2011 May;30(5):823-32.

  79. Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis
    Prabhu VS, Farnham PG, Hutchinson AB, Soorapanth S, Heffelfinger JD, Golden MR, Brooks JT, Rimland D, Sansom SL.
    PLoS One. 2011 ;6(5):e19936.

  80. Paid malpractice claims for adverse events in inpatient and outpatient settings
    Bishop TF, Ryan AK, Casalino LP.
    JAMA. 2011 Jun 15;305(23):2427-31.

  81. Medicaid payment levels to dentists and access to dental care among children and adolescents
    Decker SL.
    JAMA. 2011 Jul 13;306(2):187-93.

  82. The cost-effectiveness of interventions designed to reduce sodium intake
    Wang G, Labarthe D.
    J Hypertens. 2011 Jul 22.

  83. Health economics of cardiovascular disease: defining the research agenda
    Ferdinand KC, Orenstein D, Hong Y, Journigan JG, Trogdon J, Bowman J, Zohrabian A, Kilgore M, White A, Mokdad A, Pechacek TF, Goetzel RZ, Labarthe DR, Puckrein GA, Finkelstein E, Wang G, French ME, Vaccarino V.
    CVD Prev Control. 2011 September;6 (3):91-100.

  84. Expanding the generation and use of economic and financial data to improve HIV program planning and efficiency: a global perspective
    Holmes CB, Atun R, Avila C, Blandford JM.
    J Acquir Immune Defic Syndr. 2011 01 Aug;57 (SUPPL. 2):S104-S108.

  85. The economic effect of Planet Health on preventing bulimia nervosa
    Wang LY, Nichols LP, Austin SB.
    Arch Pediatr Adolesc Med. 2011 Aug;165(8):756-62.

  86. Prices of unhealthy foods, food stamp program participation, and body weight status among U.S. low-income women
    Zhang Q, Chen Z, Diawara N, Wang Y.
    J Fam Econ Issues. 2011 Jun;32(2):245-256.

  87. Economic analysis of nutrition interventions for chronic disease prevention: methods, research, and policy
    Wong JB, Coates PM, Russell RM, Dwyer JT, Schuttinga JA, Bowman BA, Peterson SA.
    Nutr Rev. 2011 Sep;69(9):533-549.

  88. Large cost savings realized from the 2006 Field Triage Guideline: reduction in overtriage in U.S. trauma centers
    Faul M, Wald MM, Sullivent EE, Sasser SM, Kapil V, Lerner EB, Hunt RC.
    Prehosp Emerg Care. 2011 Oct 18.

  89. Health care expenditures among children with and those without spina bifida enrolled in Medicaid in North Carolina
    Cassell CH, Grosse SD, Thorpe PG, Howell EE, Meyer RE.
    Birth Defects Res A Clin Mol Teratol. 2011 Oct 22.

  90. Return on public health investment: CDC's expanded HIV testing initiative
    Hutchinson AB, Farnham PG, Duffy N, Wolitski RJ, Sansom SL, Dooley SW, Cleveland JC, Mermin JH.
    J Acquir Immune Defic Syndr. 2011 Nov 7.

  91. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings
    Rein DB, Smith BD, Wittenborn JS, Lesesne SB, Wagner LD, Roblin DW, Patel N, Ward JW, Weinbaum CM.
    Ann Intern Med. 2011 Nov 4.

  92. Uninsurance among nonelderly adults with and without frequent mental and physical distress in the United States
    Strine TW, Zack M, Dhingra S, Druss B, Simoes E.
    Psychiatr Serv. 2011 Oct;62(10):1131-7.

  93. Incidence-based cost estimates require population-based incidence data. A critique of Mahan et al
    Grosse SD.
    Thromb Haemost. 2011 Dec 8;107(1).

  94. Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008
    Guh S, Grosse SD, McAlister S, Kessler CM, Soucie JM.
    Haemophilia. 2011 Dec 12.

  95. Aligning resources to fight HIV/AIDS in the United States: funding to states through the U.S. Department of Health and Human Services
    Mansergh G, Valdiserri RO, Yakovchenko V, Koh H.
    J Acquir Immune Defic Syndr. 2011 Dec 12.

  96. Autism spectrum disorders and health care expenditures: the effects of co-occurring conditions
    Peacock G, Amendah D, Ouyang L, Grosse SD.
    J Dev Behav Pediatr. 2011 Dec 9.

  97. The cost-effectiveness of Welcome to Medicare visual acuity screening and a possible alternative Welcome to Medicare eye evaluation among persons without diagnosed diabetes mellitus
    Rein DB, Wittenborn JS, Zhang X, Hoerger TJ, Zhang P, Klein BE, Lee KE, Klein R, Saaddine JB.
    Arch Ophthalmol. 2012 Jan 9.

  98. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations
    Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA.
    Drugs. 2012 Jan 1;72(1):35-48.

  99. The cost-effectiveness of cotrimoxazole in people with advanced HIV infection initiating antiretroviral therapy in sub-Saharan Africa
    Abimbola TO, Marston BJ.
    J Acquir Immune Defic Syndr. 2012 Jan 11.

  100. Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children
    Kancherla V, Amendah DD, Grosse SD, Yeargin-Allsopp M, Van Naarden Braun K.
    Res Dev Disabil. 2012 Jan 11;33(3):832-840.

  101. A nationwide community-based lifestyle program could delay or prevent type 2 diabetes cases and save $5.7 billion in 25 years
    Zhuo X, Zhang P, Gregg EW, Barker L, Hoerger TJ, Pearson-Clarke T, Albright A.
    Health Aff (Millwood). 2012 Jan;31(1):50-60.

  102. Coverage of newborn and adult male circumcision varies among public and private US payers despite health benefits
    Clark SJ, Kilmarx PH, Kretsinger K.
    Health Aff (Millwood). 2011 Dec;30(12):2355-61.

  103. Cost-benefit analysis of in-hospital influenza vaccination of postpartum women
    Ding Y, Zangwill KM, Hay JW, Allred NJ, Yeh SH.
    Obstet Gynecol. 2012 Feb;119(2 Pt 1):306-14.

  104. Health utility elicitation: is there still a role for direct methods?
    Prosser LA, Grosse SD, Wittenberg E.
    PharmacoEconomics. 2012 Feb 1;30(2):83-6.

  105. The economic burden of child maltreatment in the United States and implications for prevention
    Fang X, Brown DS, Florence CS, Mercy JA.
    Child Abuse Negl. 2012 Jan 31.

  106. The health and wealth of US counties: how the small business environment impacts alternative measures of development
    Blanchard TC, Tolbert C, Mencken C.
    Camb J Regions Econ Soc. 2011 December 2, 2011:1-14.

  107. Sexonomics: a commentary and review of selected sexually transmitted disease studies in the economics literature
    Chesson HW.
    Sex Transm Dis. 2012 Mar;39(3):161-6.

  108. Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness
    Kahn JG, Muraguri N, Harris B, Lugada E, Clasen T, Grabowsky M, Mermin J, Shariff S.
    PLoS One. 2012 ;7(2):e31316.

  109. Health care expenditures for Medicaid-covered males with haemophilia in the United States, 2008
    Guh S, Grosse SD, McAlister S, Kessler CM, Soucie JM.
    Haemophilia. 2012 Mar;18(2):276-83.

  110. Exposure to natural cold and heat: hypothermia and hyperthermia Medicare claims, United States, 2004-2005
    Noe RS, Jin JO, Wolkin AF.
    Am J Public Health. 2012 Apr;102(4):e11-8.

  111. Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions
    Shrestha RK, Sansom SL, Farnham PG.
    J Public Health Manag Pract. 2012 May;18(3):259-67.

  112. Economics of collaborative care for management of depressive disorders: a community guide systematic review
    Jacob V, Chattopadhyay SK, Sipe TA, Thota AB, Byard GJ, Chapman DP.
    Am J Prev Med. 2012 May;42(5):539-49.

  113. Indirect, out-of-pocket and medical costs from influenza-related illness in young children
    Ortega-Sanchez IR, Molinari NA, Fairbrother G, Szilagyi PG, Edwards KM, Griffin MR, Cassedy A, Poehling KA, Bridges C, Staat MA.
    Vaccine. 2012 Apr 27.

  114. Health care expenditures associated with venous thromboembolism among children
    Boulet SL, Amendah D, Grosse SD, Hooper WC.
    Thromb Res. 2012 May;129(5):583-7.

  115. Cost-effectiveness of the National HIV/AIDS Strategy (NHAS) goal of increasing linkage to care for HIV-infected persons
    Gopalappa C, Farnham PG, Hutchinson AB, Sansom SL.
    J Acquir Immune Defic Syndr. 2012 May 10.

  116. Reference allocations and use of a disparity measure to inform the design of allocation funding formulas in public health programs
    Buehler JW, Bernet PM, Ogden LL.
    J Public Health Manag Pract. 2012 Jul;18(4):333-8.

  117. Resource and cost adjustment in the design of allocation funding formulas in public health programs
    Buehler JW, Bernet PM, Ogden LL.
    J Public Health Manag Pract. 2012 Jul;18(4):323-32.

  118. Funding formulas for public health allocations: federal and state strategies
    Ogden LL, Sellers K, Sammartino C, Buehler JW, Bernet PM.
    J Public Health Manag Pract. 2012 Jul;18(4):309-316.

  119. Allocating HIV prevention funds in the United States: recommendations from an optimization model
    Lasry A, Sansom SL, Hicks KA, Uzunangelov V.
    PLoS One. 2012 ;7(6):e37545.

  120. Health insurance coverage: early release of estimates from the National Health Interview Survey, 2011
    Cohen RA, Martinez ME.
    Early Releases of Selected Estimates from the NHIS. 2012 June 19:1-37.

  121. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings
    Farnham PG, Sansom SL, Hutchinson AB.
    Med Decis Making. 2012 May-Jun;32(3):459-69.

  122. The potential cost-effectiveness of amblyopia screening programs
    Rein DB, Wittenborn JS, Zhang X, Song M, Saaddine JB.
    J Pediatr Ophthalmol Strabismus. 2012 May 1;49(3):146-155.

  123. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States
    Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, Markowitz LE.
    Vaccine. 2012 Aug 3.

  124. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China
    Yin Z, Beeler Asay GR, Zhang L, Li Y, Zuo S, Hutin YJ, Ning G, Sandhu HS, Cairns L, Luo H.
    Vaccine. 2012 Aug 10;30(37):5569-77.

  125. HIV treatment as prevention: issues in economic evaluation
    Barnighausen T, Salomon JA, Sangrujee N.
    PLoS Med. 2012 Jul;9(7):e1001263.

  126. Costs of, and reimbursement for, vaccines: a case study at the Board of Health Refugee Services in DeKalb county, Georgia
    Adachi K, Coleman MS, de la Motte Hurst C, Vargas ML, Oladele A, Weinberg MS.
    Vaccine. 2012 Aug 18.

  127. Economic impact of the 2009-2010 Guam mumps outbreak on the public health sector and affected families
    Mahamud A, Fiebelkorn AP, Nelson G, Aguon A, McKenna J, Villarruel G, Gallagher K, Ortega-Sanchez IR.
    Vaccine. 2012 Aug 14.

  128. Decision analysis, economic evaluation, and newborn screening: challenges and opportunities
    Prosser LA, Grosse SD, Kemper AR, Tarini BA, Perrin JM.
    Genet Med. 2012 August;14(8):703-712.

  129. Excess healthcare costs associated with prior workers' compensation activity
    Bhattacharya A, Park RM.
    Am J Ind Med. 2012 Sep 11.

  130. State-level projections of cancer-related medical care costs: 2010 to 2020
    Trogdon JG, Tangka FK, Ekwueme DU, Guy GP, Nwaise I, Orenstein D.
    Am J Manag Care. 2012 Sep;18(9):525-32.

  131. In 2011 nearly one-third of physicians said they would not accept new Medicaid patients, but rising fees may help
    Decker SL.
    Health Aff (Millwood). 2012 Aug;31(8):1673-9.

  132. Melanoma treatment costs: a systematic review of the literature, 1990-2011
    Guy GP, Ekwueme DU, Tangka FK, Richardson LC.
    Am J Prev Med. 2012 Nov;43(5):537-45.

  133. Coordination costs for school-located influenza vaccination clinics, Maine, 2009 H1N1 pandemic
    Asay GR, Cho BH, Lorick SA, Tipton ML, Dube NL, Messonnier ML.
    J Sch Nurs. 2012 Oct;28(5):328-35.

  134. Costs of school-located influenza vaccination clinics in Maine during the 2009-2010 H1N1 pandemic
    Cho BH, Asay GR, Lorick SA, Tipton ML, Dube NL, Messonnier ML.
    J Sch Nurs. 2012 Oct;28(5):336-43.

  135. Health status and health insurance coverage of women with live-born infants: an opportunity for preventive services after pregnancy
    D'Angelo DV, Williams L, Harrison L, Ahluwalia IB.
    Matern Child Health J. 2012 Nov 4.

  136. The determinants of HIV treatment costs in resource limited settings
    Menzies NA, Berruti AA, Blandford JM.
    PLoS One. 2012 ;7(11):e48726.

  137. Household economic impact and attitudes toward school closures in two cities in Argentina during the 2009 influenza A (H1N1) pandemic
    Basurto-Davila R, Garza R, Meltzer MI, Carlino OL, Albalak R, Orellano PW, Uez O, Shay DK, Santandrea C, Weis MD, Averhoff F, Widdowson MA.
    Influenza Other Respi Viruses. 2012 Nov 26.

  138. Reducing health care costs for dementia patients: estimating savings from a caregiver support program
    Klug MG, Muus K, Volkov B, Halaas GW.
    J Aging Health. 2012 Dec;24(8):1470-85.

  139. Cost implications of self-management education intervention programmes in arthritis
    Brady TJ.
    Best Pract Res Clin Rheumatol. 2012 Oct;26(5):611-25.

  140. Introduction to special issue of best practices in rheumatology: health economics of musculoskeletal diseases
    Murphy LB, Yelin E.
    Best Pract Res Clin Rheumatol. 2012 Oct;26(5):559-60.

  141. Direct healthcare costs of selected diseases primarily or partially transmitted by water
    Collier SA, Stockman LJ, Hicks LA, Garrison LE, Zhou FJ, Beach MJ.
    Epidemiol Infect. 2012 Nov;140(11):2003-13.

  142. Compromised access to prescriptions and medical care because of cost among US adults with arthritis
    Murphy LB, Yelin E, Theis KA.
    Best Pract Res Clin Rheumatol. 2012 Oct;26(5):677-94.

  143. Exploring household economic impacts of childhood diarrheal illnesses in 3 African settings
    Rheingans R, Kukla M, Adegbola RA, Saha D, Omore R, Breiman RF, Sow SO, Onwuchekwa U, Nasrin D, Farag TH, Kotloff KL, Levine MM.
    Clin Infect Dis. 2012 Dec;55 Suppl 4:S317-26.

  144. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
    Brunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, Lord J, Sisk J, Ruiz F, Hill S, Guyatt GH, Jaeschke R, Helfand M, Harbour R, Davoli M, Amato L, Liberati A, Schunemann HJ.
    J Clin Epidemiol. 2013 Feb;66(2):140-50.

  145. Billing practices of local health departments providing 2009 pandemic influenza A (H1N1) vaccine
    Lindley MC.
    J Public Health Manag Pract. 2013 Jan 28.

  146. Full coverage for hypertension drugs in rural communities in China
    Yu B, Zhang X, Wang G.
    Am J Manag Care. 2013 ;19(1):e22-9.

  147. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis
    Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG.
    Med Mycol. 2013 Feb;51(2):128-35.

  148. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008
    Owusu-Edusei K, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MC, Kent CK.
    Sex Transm Dis. 2013 Mar;40(3):197-201.

  149. Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States
    Owusu-Edusei K, Introcaso CE, Chesson HW.
    Sex Transm Dis. 2013 Mar;40(3):226-9.

  150. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009
    Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Danziger LH.
    J Antimicrob Chemother. 2013 Mar;68(3):715-8.

  151. Estimating the impact of state budget cuts and redirection of prevention resources on the HIV epidemic in 59 California local health departments
    Lin F, Lasry A, Sansom SL, Wolitski RJ.
    PLoS One. 2013 ;8(3):e55713.

  152. State-level cancer treatment costs: how much and who pays?
    Tangka FK, Trogdon JG, Ekwueme DU, Guy GP, Nwaise I, Orenstein D.
    Cancer. 2013 Apr 4.

  153. The cost-effectiveness of screening men who have sex with men for rectal chlamydial and gonococcal infection to prevent HIV infection
    Chesson HW, Bernstein KT, Gift TL, Marcus JL, Pipkin S, Kent CK.
    Sex Transm Dis. 2013 May;40(5):366-71.

  154. Utilization and cost of diagnostic methods for sexually transmitted infection screening among insured American youth, 2008
    Owusu-Edusei K, Nguyen HT, Gift TL.
    Sex Transm Dis. 2013 May;40(5):354-61.

  155. Economics of monitoring antiretroviral therapy
    Mermin J, Granich R.
    Lancet Infect Dis. 2013 Apr 17.

  156. Cost effectiveness analysis of elementary school-located vaccination against influenza-results from a randomized controlled trial
    Yoo BK, Humiston SG, Szilagyi PG, Schaffer SJ, Long C, Kolasa M.
    Vaccine. 2013 Apr 19;31(17):2156-64.

  157. Showcasing pharmaceutical economics, outcomes, and health policy: an update in clinical therapeutics
    Lau DT.
    Clin Ther. 2013 Apr;35(4):354-5.

  158. Cost savings associated with prohibiting smoking in U.S. subsidized housing
    King BA, Peck RM, Babb SD.
    Am J Prev Med. 2013 Jun;44(6):631-4.

  159. The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia
    Miller TL, Cirule A, Wilson FA, Holtz TH, Riekstina V, Cain KP, Moonan PK, Leimane V.
    Cost Eff Resour Alloc. 2013 ;11(1):9.

  160. Hypertension-associated expenditures for medication among US adults
    Wang G, Yan L, Ayala C, George MG, Fang J.
    Am J Hypertens. 2013 May 31.

  161. Medical costs associated with type 2 diabetes complications and comorbidities
    Li R, Bilik D, Brown MB, Zhang P, Ettner SL, Ackermann RT, Crosson JC, Herman WH.
    Am J Manag Care. 2013 May;19(5):421-30.

  162. A cost analysis of a community health worker program in rural Vermont
    Mirambeau AM, Wang G, Ruggles L, Dunet DO.
    J Community Health. 2013 Jun 21.

  163. Health status, risk factors, and medical conditions among persons enrolled in Medicaid vs uninsured low-income adults potentially eligible for Medicaid under the Affordable Care Act
    Decker SL, Kostova D, Kenney GM, Long SK.
    JAMA. 2013 Jun 26;309(24):2579-86.

  164. Health care costs associated with child maltreatment: impact on Medicaid
    Florence C, Brown DS, Fang X, Thompson HF.
    Pediatrics. 2013 Jul 1.

  165. A cost analysis of a community health worker program in rural Vermont
    Mirambeau AM, Wang G, Ruggles L, Dunet DO.
    J Community Health. 2013 Jun 21.

  166. Health status, risk factors, and medical conditions among persons enrolled in Medicaid vs uninsured low-income adults potentially eligible for Medicaid under the Affordable Care Act
    Decker SL, Kostova D, Kenney GM, Long SK.
    JAMA. 2013 Jun 26;309(24):2579-86.

  167. Health care costs associated with child maltreatment: impact on Medicaid
    Florence C, Brown DS, Fang X, Thompson HF.
    Pediatrics. 2013 Jul 1.

  168. Cost-utility analysis of the housing and health intervention for homeless and unstably housed persons living with HIV
    Holtgrave DR, Wolitski RJ, Pals SL, Aidala A, Kidder DP, Vos D, Royal S, Iruka N, Briddell K, Stall R, Bendixen AV.
    AIDS Behav. 2013 Jun;17(5):1626-31.

  169. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs
    Tangka FK, Subramanian S, Beebe MC, Hoover S, Royalty J, Seeff LC.
    Cancer. 2013 Aug 1;119 Suppl 15:2863-9.

  170. Hypertension-associated hospitalizations and costs in the United States, 1979-2006
    Wang G, Fang J, Ayala C.
    Blood Press. 2013 Jul 25.

  171. Two-thirds of primary care physicians accepted new medicaid patients in 2011-12: a baseline to measure future acceptance rates
    Decker SL.
    Health Aff (Millwood). 2013 Jul;32(7):1183-7.

  172. Cost-effectiveness of routine screening for critical congenital heart disease in US newborns
    Peterson C, Grosse SD, Oster ME, Olney RS, Cassell CH.
    Pediatrics. 2013 Aug 5.

  173. Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program
    Subramanian S, Tangka FK, Hoover S, Beebe MC, Degroff A, Royalty J, Seeff LC.
    Cancer. 2013 Aug 1;119 Suppl 15:2855-62.

  174. State-level estimates of cancer-related absenteeism costs
    Tangka FK, Trogdon JG, Nwaise I, Ekwueme DU, Guy GP, Orenstein D.
    J Occup Environ Med. 2013 Aug 21.

  175. Racial/ethnic differences in hospital use and cost among a statewide population of children with Down syndrome
    Derrington TM, Kotelchuck M, Plummer K, Cabral H, Lin AE, Belanoff C, Shin M, Correa A, Grosse SD.
    Res Dev Disabil. 2013 Jul 25;34(10):3276-3287.

  176. Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective
    Li C, Zeliadt SB, Hall IJ, Smith JL, Ekwueme DU, Moinpour CM, Penson DF, Thompson IM, Keane TE, Ramsey SD.
    Support Care Cancer. 2013 Aug 17.

  177. Medicare part D is associated with reducing the financial burden of health care services in medicare beneficiaries with diagnosed diabetes
    Li R, Gregg EW, Barker LE, Zhang P, Zhang F, Zhuo X, Williams DE, Soumerai SB.
    Med Care. 2013 Aug 21.

  178. Cost and threshold analysis of an HIV/STI/hepatitis prevention intervention for young men leaving prison: Project START
    Johnson AP, Macgowan RJ, Eldridge GD, Morrow KM, Sosman J, Zack B, Margolis A.
    AIDS Behav. 2013 Oct;17(8):2676-84.

  179. Cost and threshold analysis of an HIV/STI/hepatitis prevention intervention for young men leaving prison: Project START
    Johnson AP, Macgowan RJ, Eldridge GD, Morrow KM, Sosman J, Zack B, Margolis A.
    AIDS Behav. 2013 Oct;17(8):2676-84.

  180. Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia
    Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Casella JF, Fish B, Thompson BW, Grosse SD.
    Pediatrics. 2013 Oct;132(4):677-83.

  181. Economic burden of cancer survivorship among adults in the United States
    Guy GP, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, de Moor JS, Virgo KS.
    J Clin Oncol. 2013 Oct 20;31(30):3749-57.

  182. Productivity costs of nonviral sexually transmissible infections among patients who miss work to seek medical care: evidence from claims data
    Owusu-Edusei K, Roby TM, Chesson HW, Gift TL.
    Sex Health. 2013 Oct;10(5):434-7.

  183. A longitudinal view of child enrollment in Medicaid
    Simon AE, Driscoll A, Gorina Y, Parker JD, Schoendorf KC.
    Pediatrics. 2013 Oct;132(4):656-62.

  184. Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia
    Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Casella JF, Fish B, Thompson BW, Grosse SD.
    Pediatrics. 2013 Oct;132(4):677-83.

  185. Economic burden of cancer survivorship among adults in the United States
    Guy GP, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, de Moor JS, Virgo KS.
    J Clin Oncol. 2013 Oct 20;31(30):3749-57.

  186. Productivity costs of nonviral sexually transmissible infections among patients who miss work to seek medical care: evidence from claims data
    Owusu-Edusei K, Roby TM, Chesson HW, Gift TL.
    Sex Health. 2013 Oct;10(5):434-7.

  187. A longitudinal view of child enrollment in Medicaid
    Simon AE, Driscoll A, Gorina Y, Parker JD, Schoendorf KC.
    Pediatrics. 2013 Oct;132(4):656-62.

  188. Disability, health, and multiple chronic conditions among people eligible for both Medicare and Medicaid, 2005-2010
    Fox MH, Reichard A.
    Prev Chronic Dis. 2013 ;10:E157.

  189. Trends and characteristics of preventive care visits among commercially insured adolescents, 2003-2010
    Tsai Y, Zhou F, Wortley P, Shefer A, Stokley S.
    J Pediatr. 2013 Nov 25.

  190. Trends and characteristics of preventive care visits among commercially insured adolescents, 2003-2010
    Tsai Y, Zhou F, Wortley P, Shefer A, Stokley S.
    J Pediatr. 2013 Nov 25.

  191. Cost-effectiveness of screening men in Maricopa County jails for chlamydia and gonorrhea to avert infections in women
    Gopalappa C, Huang YL, Gift TL, Owusu-Edusei K, Taylor M, Gales V.
    Sex Transm Dis. 2013 Oct;40(10):776-83.

  192. Baby-friendly hospital practices and birth costs
    Allen JA, Longenecker HB, Perrine CG, Scanlon KS.
    Birth. 2013 Dec;40(4):221-6.

  193. Do zero-cost workers' compensation medical claims really have zero costs? The impact of workplace injury on group health insurance utilization and costs
    Asfaw A, Rosa R, Mao R.
    J Occup Environ Med. 2013 Dec;55(12):1394-400.

  194. Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV
    Hutchinson AB, Ethridge SF, Wesolowski LG, Shrestha RK, Pentella M, Bennett B, Farnham PG, Sullivan T, Patel P, Branson BM.
    J Clin Virol. 2013 Dec;58 Suppl 1:e2-7.

  195. Cost-effectiveness of alternative thresholds of the fasting plasma glucose test to identify the target population for type 2 diabetes prevention in adults aged >=45 years
    Zhuo X, Zhang P, Kahn HS, Gregg EW.
    Diabetes Care. 2013 Dec;36(12):3992-8.

  196. A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease
    Peterson C, Grosse SD, Glidewell J, Garg LF, Van Naarden Braun K, Knapp MM, Beres LM, Hinton CF, Olney RS, Cassell CH.
    Public Health Rep. 2014 Jan;129(1):86-93.

  197. Obesity and people with disabilities: the implications for health care expenditures
    Anderson WL, Wiener JM, Khatutsky G, Armour BS.
    Obesity (Silver Spring). 2013 Dec;21(12):E798-804.

  198. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China
    Owusu-Edusei K, Tao G, Gift TL, Wang A, Wang L, Tun Y, Wei X, Wang L, Fuller S, Kamb ML, Bulterys M.
    Sex Transm Dis. 2014 Feb;41(2):103-10.

  199. Trends in uninsured clients visiting health centers funded by the Title X family planning program - Massachusetts, 2005-2012
    Carter M, Desilets K, Gavin L, Moskosky S, Clark J.
    MMWR Morb Mortal Wkly Rep. 2014 Jan 24;63(3):59-62.

  200. Cigarette excise tax structure and cigarette prices: evidence from the global adult tobacco survey and the U.S. National Adult Tobacco Survey
    Chaloupka FJ, Kostova D, Shang C.
    Nicotine Tob Res. 2014 Jan;16 Suppl 1:S3-9.

  201. Economics of United States tuberculosis airline contact investigation policies: a return on investment analysis
    Coleman MS, Marienau KJ, Marano N, Marks SM, Cetron MS.
    Travel Med Infect Dis. 2014 Jan-Feb;12(1):63-71.

  202. The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV
    O'Brien L, Shaffer N, Sangrujee N, Abimbola TO.
    Bull World Health Organ. 2014 March;92(3):162-170.

  203. Vaccine financing from the perspective of primary care physicians
    O'Leary ST, Allison MA, Lindley MC, Crane LA, Hurley LP, Brtnikova M, Beaty BL, Babbel CI, Jimenez-Zambrano A, Berman S, Kempe A.
    Pediatrics. 2014 Mar;133(3):367-74.

  204. Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010
    Kutty PK, Lawler J, Rausch-Phung E, Ortega-Sanchez IR, Goodell S, Schulte C, Pollock L, Valure B, Hudson J, Gallagher K, Blog D.
    Hum Vaccin Immunother. 2014 Mar 14;10(5).

  205. Changes over time in high out-of-pocket health-care burden in U.S. adults with diabetes, 2001-2011
    Li R, Baker LE, Shrestha S, Zhang P, Duru OK, Pearson-Clarke T, Gregg EW.
    Diabetes Care. 2014 Mar 25.

  206. Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility -malaria
    Thomson R, Festo C, Johanes B, Kalolella A, Bruxvoort K, Nchimbi H, Tougher S, Cairns M, Taylor M, Kleinschmidt I, Ye Y, Mann A, Ren R, Willey B, Arnold F, Hanson K, Kachur SP, Goodman C.
    PLoS One. 2014 ;9(5):e95607.

  207. Cervical cancer screening with AMIGAS: a cost-effectiveness analysis
    Lairson DR, Chang YC, Byrd TL, Lee Smith J, Fernandez ME, Wilson KM.
    Am J Prev Med. 2014 Jun;46(6):617-23.

  208. Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis
    Reynolds CA, Finkelstein JA, Ray GT, Moore MR, Huang SS.
    Antimicrob Resist Infect Control. 2014 May 21;3:16.

  209. Costs of hospitalization for stroke patients aged 18-64 years in the United States
    Wang G, Zhang Z, Ayala C, Dunet DO, Fang J, George MG.
    J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):861-8.

  210. Economic review of immunization information systems to increase vaccination rates: a Community Guide systematic review
    Patel M, Pabst L, Chattopadhyay S, Hopkins D, Groom H, Myerburg S, Morgan JM.
    J Public Health Manag Pract. 2014 Jun 6.

  211. Insurance and billing concerns among patients seeking free and confidential sexually transmitted disease care: New York City sexually transmitted disease clinics 2012
    Washburn K, Goodwin C, Pathela P, Blank S.
    Sex Transm Dis. 2014 Jul;41(7):463-6.

  212. Annual patient time costs associated with medical care among cancer survivors in the United States
    Yabroff KR, Guy GP, Ekwueme DU, McNeel T, Rozjabek HM, Dowling E, Li C, Virgo KS.
    Med Care. 2014 Jul;52(7):594-601.

  213. The medical cost of abusive head trauma in the United States
    Peterson C, Xu L, Florence C, Parks SE, Miller TR, Barr RG, Barr M, Steinbeigle R.
    Pediatrics. 2014 Jun 16.

  214. Evaluation of economic costs of a measles outbreak and outbreak response activities in Keffa Zone, Ethiopia
    Wallace AS, Masresha BG, Grant G, Goodson JL, Birhane H, Abraham M, Endailalu TB, Letamo Y, Petu A, Vijayraghavan M.
    Vaccine. 2014 Jun 18.

  215. A literature review of indirect costs associated with stroke
    Joo H, George MG, Fang J, Wang G.
    J Stroke Cerebrovasc Dis. 2014 Jun 21.

  216. State-based Medicaid costs for pediatric asthma emergency department visits
    Pearson WS, Goates SA, Harrykissoon SD, Miller SA.
    Prev Chronic Dis. 2014 Jun 26;11:E108.

  217. Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel
    Hoerger TJ, Bradley C, Schillie SF, Reilly M, Murphy TV.
    Infect Control Hosp Epidemiol. 2014 Jul;35(7):845-54.

  218. Enabling reimbursement to health departments for immunization services
    Kilgus CD, Redmon GS.
    J Public Health Manag Pract. 2014 Jul-Aug;20(4):453-5.

  219. Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel
    Hoerger TJ, Bradley C, Schillie SF, Reilly M, Murphy TV.
    Infect Control Hosp Epidemiol. 2014 Jul;35(7):845-54.

  220. Enabling reimbursement to health departments for immunization services
    Kilgus CD, Redmon GS.
    J Public Health Manag Pract. 2014 Jul-Aug;20(4):453-5.

 

To subscribe to CDC Science Clips email updates, enter your email address:

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    24 Hours/Every Day
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #